ParagonRx® | Minimize Risk and Optimize Use

This program focuses on the need to be forward thinking in how to capture data and mine clinical trials for what we already know (pulling in PM safety data from existing databases) to shape future clinical trials and develop risk management plans.

Top Five Reasons to Attend:

• Discuss the role of epidemiology in mining data for risk management plan development
• Address the disconnect between expedited adverse event and clinical trial reports data collection, reconciliation and reporting
• Effectively manage the possible dispositions of safety assessments in development
• Consider potential for REMS in phase II-III clinical development
• Employ a model for anticipatory risk management planning